NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects United States. ✖Remove constraint Subjects: United States. Subjects United States ✖Remove constraint Subjects: United States Recently Added Within 6 Months ✖Remove constraint Recently Added: Within 6 Months

1. Medicare Part B drugs: trends in spending and utilization, 2008-2021

Author(s):
Nguyen, Nuguyen X., author
Olsen, T. Anders, author
Sheingold, Steven, author
De Lew, Nancy, author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, June 9, 2023
Subject(s):
Cost Control
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicare Part B -- economics
United States
United States.

2. Medicare Part D enrollee out-of-pocket spending: recent trends and projected impacts of the Inflation Reduction Act

Author(s):
Sayed, Bisma A., author
Finegold, Kenneth, 1957- author
Olsen, T. Anders, author
Ashok, Kaavya, author
Shutz, Sarah, author
Sheingold, Steven, author
De Lew, Nancy, author
Sommers, Benjamin D., author
Publication:
Washington, D.C. : Assistant Secretary for Planning and Evaluation, Office of Health Policy, July 7, 2023
Subject(s):
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicare Part D -- economics
Medicare Part D -- statistics & numerical data
State Government
United States
United States.

7. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):
Biological Products
Clinical Trials as Topic
Data Analysis
Decision Making
Drug Approval
Drug Industry
Drug and Narcotic Control
Government Regulation
United States
United States.

8. Wholesale distributor verification requirement for saleable returned drug product and dispenser verification requirements when investigating a suspect or illegitimate product: compliance policies : guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):
Counterfeit Drugs
Drug Industry
Drug and Narcotic Control
Fraud
Government Regulation
Substandard Drugs
United States
United States.

9. The Bipartisan Safer Communities Act: where things stand on the Medicaid and CHIP provisions

Author(s):
Dwyer, Anne, (Of Georgetown University. Center for Children and Families), author
Publication:
[Washington, DC] : Georgetown University Health Policy Institute, Center for Children and Families, August 2023
Subject(s):
Behavioral Medicine
Health Policy
Health Services Accessibility
Medicaid
Mental Health Services
Social Determinants of Health
United States
United States.
Children's Health Insurance Program (U.S.)

12. CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
Government Regulation
Legislation, Medical
Politics
Professional Misconduct
United States
United States.
United States. Department of Health and Human Services

13. Medicare cognitive assessments: utilization tripled between 2018 and 2022, but challenges remain : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, December 2023
Subject(s):
Alzheimer Disease
Government Regulation
Healthcare Disparities
Medicare
Mental Status and Dementia Tests -- statistics & numerical data
Neurocognitive Disorders
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)